Gene Variant Behind Newly Found Eye Disease That Dims Night Vision
A variant of the EFEMP1 gene causes a late-onset eye disease that first hits night and side vision, JAMA Ophthalmology reports. How doctors can spot it early.

Researchers have described a newly identified inherited eye disease caused by a variant of the EFEMP1 gene called p.Arg140Trp. People who carry it usually see well for most of their lives, then slowly lose side vision and have trouble seeing at dusk and at night. The study appeared in JAMA Ophthalmology.
The team found an early warning sign: the eyes of affected people take unusually long to adjust to darkness, even while the retina still looks normal on scans.
How a 1998 family case led to a new diagnosis
The work traces back to a clinical report on a family in the United States in 1998. Doctors thought the family’s eye problems looked like a condition caused by variants in a different gene, C1QTNF5, but genetic tests found none of the known variants. Collaborators then turned up the new change in EFEMP1.
That was a surprise, because EFEMP1 was already tied to another disease. A different variant of the same gene, p.Arg345Trp, damages the macula first. The macula is the small central part of the retina used for reading and recognizing faces. The newly found variant starts at the outer edge of the retina instead, and it causes abnormally thick material to build up between cells in the eye.
The researchers are calling the condition EFEMP1-associated late-onset retinal degeneration, or L-ORD, though it has no formal name yet.
What the researchers measured
With the gene identified, the team looked for it in Europe and found three unrelated families in different countries that carried p.Arg140Trp. They compared these families with another family carrying p.Arg345Trp, the variant behind the central-vision disease.
The key test was dark adaptation, the way vision recovers after a person moves from a bright room into dim light. That recovery depends on rods, the cells in the retina that handle low-light vision. In people with L-ORD, rod recovery was badly slowed in retinas that still looked structurally intact.
Artur V. Cideciyan, co-director of the Center for Hereditary Retinal Degenerations, said this gives researchers “a functional marker of disease” before the light-sensing cells die off.
The international team included scientists from the Scheie Eye Institute at the University of Pennsylvania’s Perelman School of Medicine, along with the University of Edinburgh, the University of Basel, Charles University and the University of Bonn. The paper was published Sept. 10, 2026 (DOI: 10.1001/jamaophthalmol.2026.3828).
What is still unknown
The findings come from a small number of families, and the researchers do not yet know how common the p.Arg140Trp variant is or how many people have this form of L-ORD. They suspect it is fairly rare. Larger studies are needed to answer that.
The study describes the disease and a way to detect it. It does not test any treatment.
Why it matters beyond a rare disease
Because L-ORD develops slowly from the edge of the retina, it is easy to miss until vision loss is well underway. A simple measure of how fast eyes adapt to the dark could flag it years earlier, while the retina still looks healthy.
The researchers also see a link to far more common problems. Tomas S. Aleman, a professor of ophthalmology and the center’s other co-director, noted that aging is a risk factor for retinal diseases such as age-related macular degeneration, the most common retinal condition of aging. He said rare late-onset genetic diseases like this one offer “glimpses at possible mechanisms of disease” for those much more frequent conditions.
Source: SciTechDaily



